These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19191733)

  • 1. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
    Pfäfflin A
    Clin Chem Lab Med; 2009; 47(2):242-3. PubMed ID: 19191733
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between total prothrombin, native prothrombin and the International Normalized Ratio (INR).
    Braun PJ; Szewczyk KM
    Thromb Haemost; 1992 Aug; 68(2):160-4. PubMed ID: 1412161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative extrinsic coagulation pathway and oral anticoagulant treatment.
    Cassetti M; Palazzesi G; Trimarchi A; Barzetta R
    Quad Sclavo Diagn; 1984 Mar; 20(1):105-9. PubMed ID: 6494410
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Laboratory control of oral anticoagulants.
    Lancet; 1975 Feb; 1(7902):317-8. PubMed ID: 46454
    [No Abstract]   [Full Text] [Related]  

  • 6. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
    Berkovsky A; Sergeeva EV; Suvorov AV; Uljavova IS; Kachalova ND; Klimovich LG; Samsonova NN; Kozlov AA
    Clin Chem Lab Med; 2006; 44(10):1214-7. PubMed ID: 17032133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Quick and Owren prothrombin time methods for oral anticoagulant therapy do not agree well using the International Normalized Ratio (INR) units.
    Horsti J
    Scand J Clin Lab Invest; 2003; 63(6):455-6. PubMed ID: 14594327
    [No Abstract]   [Full Text] [Related]  

  • 8. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
    Jackson CM; Esnouf MP
    Clin Chem; 2005 Mar; 51(3):483-5. PubMed ID: 15738512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring oral anticoagulant therapy--INR values for the Owren prothrombin time.
    Jackson CM
    Thromb Haemost; 2004 Feb; 91(2):210-2. PubMed ID: 14961145
    [No Abstract]   [Full Text] [Related]  

  • 13. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 14. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
    van Ryn J; Stangier J; Haertter S; Liesenfeld KH; Wienen W; Feuring M; Clemens A
    Thromb Haemost; 2010 Jun; 103(6):1116-27. PubMed ID: 20352166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine].
    Seiler K; Müller G; Duckert F
    Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitamin K antagonists: mechanism of anticoagulant action and laboratory control over therapy (a lecture)].
    Lipatova NA; Titaeva EV; Dobrovol'skiĭ AB
    Klin Lab Diagn; 2006 May; (5):25-32. PubMed ID: 16827235
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.